Innovation
5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 441 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 5.6K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Novartis Venture Fund, Columbus Venture Partners, Pfizer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Private equity | 3 | 30% |
| Other / undisclosed | 1 | 10% |
Recent activity
6 May 2026
Event
Annual Congress of the American Society of Gene & Cell Therapy (ASGCT)
7 Nov 2025
Event
Jefferies Global Healthcare Conference
15 Oct 2025
Event
ESGCT Sevilla